Multidrug (MDT) regimen under the National Leprosy Eradication Program for treatment of all Multibacillary Leprosy would include:-
**Core Concept**
The National Leprosy Eradication Program's multidrug therapy (MDT) regimen is a combination of antibiotics used to treat multibacillary leprosy, a severe form of the disease. The regimen aims to eliminate the causative bacteria, Mycobacterium leprae, from the body.
**Why the Correct Answer is Right**
The MDT regimen for multibacillary leprosy consists of rifampicin, clofazimine, and dapsone. Rifampicin is a potent bactericidal agent that inhibits RNA synthesis in M. leprae, while clofazimine has antimicrobial and anti-inflammatory properties. Dapsone, an antibacterial agent, targets the bacterial cell wall. The combination of these three drugs ensures effective bactericidal activity against M. leprae.
**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because it does not include rifampicin, which is a crucial component of the MDT regimen.
**Option B:** This option is incorrect because it does not include clofazimine, which provides anti-inflammatory properties and helps in the management of leprosy reactions.
**Option C:** This option is incorrect because it does not include dapsone, which is essential for targeting the bacterial cell wall.
**Clinical Pearl / High-Yield Fact**
The MDT regimen for multibacillary leprosy has been shown to be highly effective in reducing the bacterial load and preventing the development of resistance. It is essential to complete the full course of treatment to ensure successful eradication of the disease.
**Correct Answer:** C. Rifampicin, clofazimine, and dapsone.